Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Safety and IOP-Lowering Efficacy of Brinzolamide 10 mg/mL/Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension and Brimonidine 2 mg/mL Eye Drops, Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
brinzolamide
C-10-040
NCT01310777
Open-Angle Glaucoma; Ocular Hypertension
Phase 3
 
Alcon is a division of Novartis
June 2016

Powered by ideaPoint, Inc.